Isaac Barchas
Vermögen: 2 Mio $ am 31.05.2026
Vermögen: 2 Mio $ am 31.05.2026
Isaac Barchas was the founder of Eradivir, Inc., founded in 2020, where the title held was Director.
Mr. Barchas is also the founder of MorphImmune, Inc...
Mr. Barchas is currently Lead Independent Director at Immunome, Inc. since 2023.
Mr. Barchas is Director at Pecan Street, Inc. Mr. Barchas is Director at Novosteo, Inc. Mr. Barchas is Managing Director at Arsenal Bridge Venture II LLC.
Mr. Barchas is Managing Director at Rbp Catalyst Fund 1.
Mr. Barchas is Director at Tetricus, Inc. Mr. Barchas is Founding Partner at Arsenal Bridge Ventures.
Formerly, Mr. Barchas was President & Chief Executive Officer at Research Bridge Partners from 2017 to 2024.
Mr. Barchas was Independent Director at Sustainable Opportunities Acquisition Corp.
from 2020 to 2021.
Mr. Barchas was Director at Austin Technology Incubator from 2006 to 2016.
Mr. Barchas was Board member at The Austin Chamber of Commerce from 2007 to 2009.
Education includes an undergraduate degree from Stanford University conferred in 1989, and graduate and doctorate degrees from The University of Chicago conferred in 1993.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IMMUNOME, INC. 0,08 % | 01.02.2026 | 92.211 ( 0,08 % ) | 2 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNOME, INC. | Direktor/Vorstandsmitglied | 02.10.2023 |
Pecan Street, Inc.
Pecan Street, Inc. Miscellaneous Commercial ServicesCommercial Services Researches on water and energy | Direktor/Vorstandsmitglied | - |
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing oncology therapeutics | Gründer | - |
Tetricus, Inc.
Tetricus, Inc. Packaged SoftwareTechnology Services Builds software for psychiatric hospitals | Direktor/Vorstandsmitglied | - |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug to reduce complications from a broken bone due to a fall | Direktor/Vorstandsmitglied | - |
Arsenal Bridge Venture Ii LLC | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
Research Bridge Partners /Venture Capital/
Research Bridge Partners /Venture Capital/ Investment ManagersFinance Research Bridge Partners invests in companies located in the United States. The firm focuses on a biomedical sector. It provides finance for seed stage capital requirements. | Vorstandsvorsitzender | 01.01.2024 |
| SUSE OPPO | Direktor/Vorstandsmitglied | 01.09.2021 |
Austin Technology Incubator
Austin Technology Incubator Miscellaneous Commercial ServicesCommercial Services Operates as a technology business incubator | Direktor/Vorstandsmitglied | 01.01.2016 |
| ░░░ ░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 13 |
|---|---|
Immunome, Inc.
Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Austin Chamber of Commerce
The Austin Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services Chamber of Commerce | Commercial Services |
Austin Technology Incubator
Austin Technology Incubator Miscellaneous Commercial ServicesCommercial Services Operates as a technology business incubator | Commercial Services |
Pecan Street, Inc.
Pecan Street, Inc. Miscellaneous Commercial ServicesCommercial Services Researches on water and energy | Commercial Services |
Research Bridge Partners /Venture Capital/
Research Bridge Partners /Venture Capital/ Investment ManagersFinance Research Bridge Partners invests in companies located in the United States. The firm focuses on a biomedical sector. It provides finance for seed stage capital requirements. | Finance |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug to reduce complications from a broken bone due to a fall | Health Technology |
Sustainable Opportunities Acquisition Corp.
Sustainable Opportunities Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Eradivir, Inc.
Eradivir, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for infectious diseases | Health Technology |
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing oncology therapeutics | Health Technology |
Arsenal Bridge Venture Ii LLC | |
Tetricus, Inc.
Tetricus, Inc. Packaged SoftwareTechnology Services Builds software for psychiatric hospitals | Technology Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen